Teladoc Health Inc
For the period ended Dec 31, 2023. Filed Feb 23, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 23, 2024
TDOC$8.98+2.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
EXHIBIT INDEX
| Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| ExhibitNumber | Exhibit Description | Form | File No. | Exhibit | FilingDate | FiledHerewith |
| 2.1 | Agreement and Plan of Merger, dated August 5, 2020, by and among Teladoc Health, Inc., Tempranillo Merger Sub, Inc. and Livongo Health, Inc. | 8-K | 001-37477 | 2.1 | 8/6/20 | |
| 3.1 | Seventh Amended and Restated Certificate of Incorporation of Teladoc Health, Inc. | 8-K | 001-37477 | 3.1 | 6/2/22 | |
| 3.2 | Seventh Amended and Restated Bylaws of Teladoc Health, Inc. | * | ||||
| 4.1 | Specimen stock certificate evidencing shares of the common stock. | 10-Q | 001-37477 | 4.1 | 11/1/18 | |
| 4.2 | Indenture, dated as of May 8, 2018, by and between Teladoc, Inc. and Wilmington Trust, National Association. | 8-K | 001-37477 | 4.1 | 5/8/18 | |
| 4.3 | Global 1.375% Convertible Senior Note due 2025, dated as of May 8, 2018. | 8-K | 001-37477 | 4.2 | 5/8/18 | |
| 4.4 | Indenture, dated as of May 19, 2020, by and between Teladoc Health, Inc. and Wilmington Trust, National Association. | 8-K | 001-37477 | 4.1 | 5/19/20 | |
| 4.5 | Global 1.25% Convertible Senior Note due 2027, dated as of May 19, 2020 (included as Exhibit A to Exhibit 4.4). | 8-K | 001-37477 | 4.2 | 5/19/20 | |
| 4.6 | Indenture, dated as of June 4, 2020, by and between Livongo Health, Inc. and U.S. Bank National Association. | 8-K | 001-38983 | 4.1 | 10/30/20 | |
| 4.7 | Global 0.875% Convertible Senior Note due 2025 (included as Exhibit A to Exhibit 4.6). | 8-K | 001-38983 | 4.1 | 10/30/20 | |
| 4.8 | First Supplemental Indenture, dated as of October 30, 2020, among Livongo Health, Inc., Teladoc Health, Inc. and U.S. Bank National Association, as trustee. | 8-K | 001-37477 | 4.1 | 10/30/20 | |
| 4.9 | Second Supplemental Indenture, dated as of January 1, 2023, among Livongo Health, Inc., Teladoc Health, Inc. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee. | 10-K | 001-37477 | 4.9 | 3/1/23 | |
| 4.10 | Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934, as amended. | 10-K | 001-37477 | 4.10 | 3/1/23 | |
| 10.1+ | Form of Indemnification Agreement between Teladoc Health, Inc. and each of its directors and officers. | S-1/A | 333-204577 | 10.7 | 6/18/15 | |
| 10.2+ | Form of Indemnification Agreement between Teladoc Health, Inc. and each of its directors and officers (form used since October 2020). | 10-K | 001-37477 | 10.2 | 3/1/21 |
| 10.3+ | Teladoc Health, Inc. 2015 Incentive Award Plan (as amended and restated effective May 25, 2017). | 8-K | 001-37477 | 10.1 | 5/31/17 |
| 10.4+ | Form of Stock Option Agreement under the Teladoc Health, Inc. 2015 Incentive Award Plan. | S-1/A | 333-204577 | 10.11 | 6/18/15 |
| 10.5+ | Form of Restricted Stock Agreement under the Teladoc Health, Inc. 2015 Incentive Award Plan. | S-1/A | 333-204577 | 10.12 | 6/18/15 |
| 10.6+ | Form of Restricted Stock Unit Agreement under the Teladoc Health, Inc. 2015 Incentive Award Plan. | S-1/A | 333-204577 | 10.13 | 6/18/15 |
| 10.7+ | Form of Performance Restricted Stock Unit Agreement under the Teladoc Health, Inc. 2015 Incentive Award Plan. | 10-Q | 001-37477 | 10.1 | 5/2/22 |
| 10.8+ | Teladoc Health, Inc. 2015 Employee Stock Purchase Plan. | 10-Q | 001-37477 | 10.1 | 8/2/21 |
| 10.9+ | Second Amendment to Teladoc Health, Inc. Amended and Restated Employee Stock Purchase Plan. | 8-K | 001-37477 | 10.2 | 5/30/23 |
| 10.10+ | Teladoc Health, Inc. 2017 Employment Inducement Incentive Award Plan (as amended on July 11, 2017). | S-8 | 333-219275 | 99.3 | 7/14/17 |
| 10.11+ | Form of Stock Option Agreement under the Teladoc Health, Inc. 2017 Employment Inducement Incentive Award Plan. | 10-K | 001-37477 | 10.17 | 3/1/17 |
| 10.12+ | Form of Restricted Stock Agreement under the Teladoc Health, Inc. 2017 Employment Inducement Incentive Award Plan. | 10-K | 001-37477 | 10.18 | 3/1/17 |
| 10.13+ | Form of Restricted Stock Unit Agreement under the Teladoc Health, Inc. 2017 Employment Inducement Incentive Award Plan. | 10-K | 001-37477 | 10.19 | 3/1/17 |
| 10.14+ | Teladoc Health, Inc. Livongo Acquisition Incentive Award Plan. | S-8 | 333-249892 | 99.1 | 11/6/20 |
| 10.15+ | Form of Stock Option Agreement under the Teladoc Health, Inc. Livongo Acquisition Incentive Award Plan. | 10-K | 001-37477 | 10.14 | 3/1/21 |
| 10.16+ | Form of Restricted Stock Agreement under the Teladoc Health, Inc. Livongo Acquisition Incentive Award Plan. | 10-K | 001-37477 | 10.15 | 3/1/21 |
| 10.17+ | Form of Restricted Stock Unit Agreement under the Teladoc Health, Inc. Livongo Acquisition Incentive Award Plan. | 10-K | 001-37477 | 10.16 | 3/1/21 |
| 10.18+ | Teladoc Health, Inc. 2023 Incentive Award Plan. | 8-K | 001-37477 | 10.1 | 5/30/23 |
| 10.19+ | Form of Stock Option Agreement under the Teladoc Health, Inc. 2023 Incentive Award Plan. | 10-Q | 001-37477 | 10.2 | 7/28/23 | |
| 10.20+ | Form of Restricted Stock Agreement under the Teladoc Health, Inc. 2023 Incentive Award Plan. | 10-Q | 001-37477 | 10.3 | 7/28/23 | |
| 10.21+ | Form of Restricted Stock Unit Agreement under the Teladoc Health, Inc. 2023 Incentive Award Plan. | 10-Q | 001-37477 | 10.4 | 7/28/23 | |
| 10.22+ | Form of Performance Restricted Stock Unit Agreement under the Teladoc Health, Inc. 2023 Incentive Award Plan. | 10-Q | 001-37477 | 10.5 | 7/28/23 | |
| 10.23+ | Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan. | S-8 | 333-273509 | 99.1 | 7/28/23 | |
| 10.24+ | Form of Stock Option Agreement under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan. | 10-Q | 001-37477 | 10.2 | 10/27/23 | |
| 10.25+ | Form of Restricted Stock Agreement under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan. | 10-Q | 001-37477 | 10.3 | 10/27/23 | |
| 10.26+ | Form of Restricted Stock Unit Agreement under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan. | 10-Q | 001-37477 | 10.4 | 10/27/23 | |
| 10.27+ | Form of Performance Restricted Stock Unit Agreement under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan. | 10-Q | 001-37477 | 10.5 | 10/27/23 | |
| 10.28+ | Teladoc Health, Inc. Level 14 Severance Plan. | 8-K | 001-37477 | 10.3 | 5/30/23 | |
| 10.29+ | Teladoc Health, Inc. Non-Employee Director Compensation Program (as amended). | * | ||||
| 10.30+ | Teladoc Health, Inc. Deferred Compensation Plan for Non-Employee Directors. | 10-K | 001-37477 | 10.8 | 2/27/18 | |
| 10.31+ | Amended and Restated Executive Employment Agreement, dated June 16, 2015, by and between Teladoc Health, Inc. and Jason Gorevic. | S-1/A | 333-204577 | 10.19 | 6/18/15 | |
| 10.32+ | Amendment No. 1 to Amended and Restated Executive Employment Agreement, dated October 29, 2019, by and between Teladoc Health, Inc. and Jason Gorevic. | 10-Q | 001-37477 | 10.2 | 10/30/19 | |
| 10.33+ | Executive Severance Agreement, dated June 24, 2019, by and between Teladoc Health, Inc. and Mala Murthy. | 10-Q | 001-37477 | 10.1 | 7/31/19 | |
| 10.34+ | Amendment No. 1 to Executive Severance Agreement, dated October 29, 2019, by and between Teladoc Health, Inc. and Mala Murthy. | 10-Q | 001-37477 | 10.5 | 10/30/19 | |
| 10.35+ | Offer Letter, dated March 19, 2021, by and between Teladoc Health, Inc. and Claus Jensen. | 10-K | 001-37477 | 10.24 | 3/1/23 | |
| 10.36+ | Home Office Operating Agreement, dated January 1, 2023, by and between Teladoc Health, Inc. and Claus Jensen. | 10-K | 001-37477 | 10.25 | 3/1/23 | |
| 10.37+ | Separation and Release of Claims Agreement, dated December 1, 2023, by and between Teladoc Health, Inc. and Claus Jensen. | * | ||||
| 10.38+ | Executive Employment Agreement, dated October 2, 2022, by and between Teladoc Health, Inc. and Laizer Kornwasser. | 8-K | 001-37477 | 10.1 | 10/28/22 | |
| 10.39+ | Executive Severance Agreement, dated July 15, 2015, by and between Teladoc Health, Inc. and Daniel Trencher. | * | ||||
| 10.40+ | Amendment No. 1 to Executive Severance Agreement, dated June 9, 2023, by and between Teladoc Health, Inc. and Daniel Trencher. | 10-Q | 001-37477 | 10.8 | 7/28/23 | |
| 10.41+ | Executive Severance Agreement, dated July 15, 2015, by and between Teladoc Health, Inc. and Andrew Turitz. | * | ||||
| 10.42+ | Amendment No. 1 to Executive Severance Agreement, dated October 29, 2019, by and between Teladoc Health, Inc. and Andrew Turitz. | * | ||||
| 10.43+ | Amendment No. 2 to Executive Severance Agreement, dated June 9, 2023, by and between Teladoc Health, Inc. and Andrew Turitz. | 10-Q | 001-37477 | 10.9 | 7/28/23 | |
| 10.44+ | Executive Severance Agreement, dated July 15, 2015, by and between Teladoc Health, Inc. and Adam Vandervoort. | 10-Q | 001-37477 | 10.17 | 4/30/19 | |
| 10.45+ | Amendment No. 1 to Executive Severance Agreement, dated October 29, 2019, by and between Teladoc Health, Inc. and Adam Vandervoort. | 10-Q | 001-37477 | 10.8 | 10/30/19 | |
| 10.46+ | Executive Severance Agreement, dated January 4, 2016, by and between Teladoc Health, Inc. and Stephany Verstraete. | 10-Q | 001-37477 | 10.18 | 4/30/19 | |
| 10.47+ | Amendment No. 1 to Executive Severance Agreement, dated October 29, 2019, by and between Teladoc Health, Inc. and Stephany Verstraete. | 10-Q | 001-37477 | 10.9 | 10/30/19 | |
| 10.48+ | Executive Employment Agreement, dated June 15, 2022, by and between Teladoc Health, Inc. and Michael Waters. | 10-Q | 001-37477 | 10.1 | 11/2/22 | |
| 21.1 | Subsidiaries of the Registrant. | * | ||||
| 23.1 | Consent of Ernst & Young, LLP, Independent Registered Public Accounting Firm | * | ||||
| 31.1 | Chief Executive Officer—Certification pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | * |
| 31.2 | Chief Financial Officer—Certification pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | * |
| 32.1 | Chief Executive Officer—Certification pursuant to Rule13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ** |
| 32.2 | Chief Financial Officer—Certification pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ** |
| 97.1 | Teladoc Health, Inc. Incentive-Based Compensation Recovery Policy. | * |
| 101.INS | XBRL Instance Document. | * |
| 101.SCH | XBRL Taxonomy Extension Schema Document. | * |
| 101.CAL | XBRL Taxonomy Calculation Linkbase Document. | * |
| 101.DEF | XBRL Definition Linkbase Document. | * |
| 101.LAB | XBRL Taxonomy Label Linkbase Document. | * |
| 101.PRE | XBRL Taxonomy Presentation Linkbase Document. | * |
| 104 | Cover Page Interactive Data File – The Cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
*Filed herewith.
**Furnished herewith.
+Management contract or compensatory plan.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.